Name:  ___.                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Morbid obesity
 
Major Surgical or Invasive Procedure:
___: laparoscopic sleeve gastrectomy

 
History of Present Illness:
Per Dr. ___ is a ___ male 
referred for evaluation gastric restrictive surgery in the 
treatment and management of morbid obesity by his primary care 
provider ___ 
- ___ in ___.  ___ was seen and 
evaluated in our ___ clinic on ___, 
___ and ___.

___ has class III morbid obesity with weight of 385.6 pounds as 
of ___ with his initial screen weight of 409.3 pounds on 
___, height of 72.5 inches and BMI of 51.9.  This previous 
weight loss efforts have included chest, the ___ diet, 
personal trainer, off-label prescription weight loss medications 
fenfluramine/phentermine ("Fen/Phen"), "bodybuilding stack",
over-the-counter ephedra-containing supplements, caffeine and 
aspirin before workouts and PCP-guided weight loss losing up to 
100 pounds but his weight loss attempts at failed to produce 
significant and/or lasting results.  He stated that his lowest 
adult weight was 185 pounds at age ___ and his highest weight was
his initial screen weight of 409 pounds.  He weighed 328 pounds 
___ years ago and 393 pounds one year ago.  He stated that he has 
been struggling with weight since childhood and cites as factors 
contributing to his excess weight large portions, late-night 
eating, convenience eating, boredom and lack of exercise limited 
to conditions of knee pain and shortness of breath.  He does 
walk his dog for 30 minutes daily.  He denied history of eating 
disorders and he denied binge eating.  He does not have a 
clinical diagnosis of depression except for situational around 
his weight and he has not been seen by a therapist nor has she 
been hospitalized for mental health issues and he is not on any 
psychotropic medications.

 
Past Medical History:
1)  hypertension
2)  obstructive sleep apnea uses BiPAP 
3)  gastroesophageal reflux (minimal by UGI)
4)  asthma with no recent flares or prednisone taper
5)  history of kidney stones
6)  hyperuricemia
7)  rheumatoid arthritis
8)  hepatic steatosis by ultrasound
9)  iron deficiency with saturation of 16.4%
10) pre-diabetes with hemoglobin A1c of 6.1%.

His surgical history is noted for:

1)  umbilical hernia repair in ___
2)  bowel resection in ___
3)  right hand fingertip (index finger) amputation in ___
4)  repair of left hammertoe
5)  wisdom teeth extraction

 
Social History:
___
Family History:
His family history is unknown as he is adopted.

 
Physical Exam:
Per resident:
VS: 24 HR Data (last updated ___ @ 550)
    Temp: 98.2 (Tm 99.0), BP: 152/74 (146-155/53-74), HR: 68
(68-83), RR: 18 (___), O2 sat: 93% (92-95), O2 delivery: CPAP  

GEN: A&Ox3, NAD, resting comfortably 
HEENT: NCAT, EOMI, sclera anicteric
CV: RRR
PULM: no respiratory distress
ABD: soft, appropriately tender, mildly distended, no rebound or
guarding 
EXT: warm, well-perfused, no edema 
PSYCH: normal insight, memory, and mood
WOUND(S): Incisions c/d/i

 
Pertinent Results:
___ 05:46AM BLOOD Hct-37.0*
___ 04:45PM BLOOD Hct-38.3*
___ 05:46AM BLOOD cTropnT-<0.01
___ 09:59PM BLOOD cTropnT-<0.01
 
Brief Hospital Course:
The patient presented to pre-op on ___. Patient was 
evaluated by anaesthesia.  The patient was taken to the 
operating room for a laparoscopic sleeve gastrectomy for 
obesity. There were no adverse events in the operating room; 
please see the operative note for details. Pt was extubated, 
taken to the PACU until stable, then transferred to the ward for 
observation.  
 Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA. Pain was 
very well controlled. The patient was then transitioned to 
liquid oral pain medication once tolerating a stage 3 diet.  
 CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.  He did report 
chest discomfort in the PACU for which and EKG was obtaining and 
not concerning for an ischemic event.  Additionally, troponins 
were monitored and remained negative.
 Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization.  
 GI/GU/FEN: The patient was initially kept NPO. Afterwards, the 
patient was started on a stage 1 bariatric diet, which the 
patient tolerated well. Subsequently, the patient was advanced 
to stage 2, and then stage 3 diet which the patient was 
tolerating on day of discharge.  
 ID: The patient's fever curves were closely watched for signs 
of infection, of which there were none.  
 HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.  
 Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.  
 At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable. The patient was tolerating a 
bariatric stage 3 diet, ambulating, voiding without assistance, 
and pain was well controlled. The patient received discharge 
teaching and ___ instructions with understanding 
verbalized and agreement with the discharge plan.  

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild 
2. Lisinopril 40 mg PO DAILY 
3. Meclizine 25 mg PO ASDIR 
4. omega 3-dha-epa-fish oil ___ mg oral BID 
5. metHOTREXate sodium 2.5 mg oral 1X/WEEK 
6. metHOTREXate sodium 25 mg/mL injection 1X/WEEK 
7. amLODIPine 5 mg PO DAILY 
8. adalimumab 40 mg/0.8 mL subcutaneous ASDIR 
9. Furosemide 20 mg PO BID 
10. Multivitamins 1 TAB PO BID 
11. TraMADol 50 mg PO ASDIR 
12. Fluticasone Propionate 110mcg 2 PUFF IH BID 
13. Diclofenac Sodium ___ 75 mg PO DAILY 
14. Omeprazole 20 mg PO DAILY 
15. Aspirin 81 mg PO DAILY 
16. albuterol sulfate 90 mcg/actuation inhalation ASDIR 
17. FoLIC Acid 1 mg PO DAILY 
18. Vitamin D ___ UNIT PO ASDIR 

 
Discharge Medications:
1.  Docusate Sodium 100 mg PO BID:PRN constipation 
RX *docusate sodium 50 mg/5 mL 10 ml by mouth twice a day 
Refills:*0 
2.  OxycoDONE Liquid 5 mg PO Q4H:PRN Pain - Moderate 
RX *oxycodone 5 mg/5 mL 5 mg by mouth every four (4) hours 
Refills:*0 
3.  Acetaminophen (Liquid) 650 mg PO Q6H:PRN Pain - Mild 
  Reason for PRN duplicate override: Alternating agents for 
similar severity
RX *acetaminophen 650 mg/20.3 mL 20 ml by mouth every six (6) 
hours Disp #*300 Milliliter Refills:*0 
4.  albuterol sulfate 90 mcg/actuation inhalation ASDIR  
5.  amLODIPine 5 mg PO DAILY  
6.  Aspirin 81 mg PO DAILY  
7.  Fluticasone Propionate 110mcg 2 PUFF IH BID  
8.  FoLIC Acid 1 mg PO DAILY  
9.  Furosemide 20 mg PO BID  
10.  Lisinopril 40 mg PO DAILY  
11.  Meclizine 25 mg PO ASDIR  
12.  Multivitamins 1 TAB PO BID  
13.  omega 3-dha-epa-fish oil ___ mg oral BID  
14.  Omeprazole 20 mg PO DAILY 
Open capsule; sprinkle contents onto applesauce, swallow whole.  

15.  Vitamin D ___ UNIT PO ASDIR  
16. HELD- adalimumab 40 mg/0.8 mL subcutaneous ASDIR  This 
medication was held. Do not restart adalimumab until you discuss 
with Dr. ___ at your ___ appointment.
17. HELD- metHOTREXate sodium 2.5 mg oral 1X/WEEK  This 
medication was held. Do not restart metHOTREXate sodium until 
you discuss with Dr. ___ at your ___ visit.
18. HELD- metHOTREXate sodium 25 mg/mL injection 1X/WEEK  This 
medication was held. Do not restart metHOTREXate sodium until 
you discuss with Dr. ___ at your ___ visit.

Please notify your primary care provider and rheumatologist of 
this medication change immediately.  
19. HELD- TraMADol 50 mg PO ASDIR  This medication was held. Do 
not restart TraMADol until you are no longer taking oxycodone.

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid obesity
Obstructive sleep apnea

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___, 

You have undergone a laparoscopic sleeve gastrectomy, recovered 
in the hospital and are now preparing for discharge with the 
following instructions:

Discharge Instructions: Please call your surgeon or return to 
the Emergency Department if you develop a fever greater than 101 
F, shaking chills, chest pain, difficulty breathing, pain with 
breathing, cough, a rapid heartbeat, dizziness, severe abdominal 
pain, pain unrelieved by your pain medication, a change in the 
nature or severity of your pain, severe nausea, vomiting, 
abdominal bloating, severe diarrhea, inability to eat or drink, 
foul smelling or colorful drainage from your incisions, redness, 
swelling from your incisions, or any other symptoms which are 
concerning to you.
Diet: Stay on Stage III diet until your follow up appointment; 
please refer to your work book for detailed instructions. Do not 
self- advance your diet and avoid drinking with a straw or 
chewing gum. To avoid dehydration, remember to sip small amounts 
of fluid frequently throughout the day to reach a goal of 
approximately ___ mL per day. Please note the following signs 
of dehydration: dry mouth, rapid heartbeat, feeling dizzy or 
faint, dark colored urine, infrequent urination. 

Medication Instructions:
Please refer to the medication list provided with your discharge 
paperwork for detailed instruction regarding your home and newly 
prescribed medications.  
Some of the new medications you will be taking include:
1.  Pain medication: You will receive a prescription for liquid 
oxycodone, an opioid pain medication.  This medication will make 
you drowsy and impair your ability to drive a motor vehicle or 
operate machinery safely. You MUST refrain from such activities 
while taking these medications. You may also take acetaminophen 
(Tylenol) for pain management; do not exceed 4000 mg per 24 hour 
period.
2. Constipation: This is a common side effect of opioid pain 
medication.  If you experience constipation, please reduce or 
eliminate opioid pain medication.  You may trial 2 ounces of 
light prune juice and/or a stool softener (i.e. crushed docusate 
sodium tablets), twice daily until you resume a normal bowel 
pattern.  Please stop taking this medication if you develop 
loose stools. Please do not begin taking laxatives including 
until you have discussed it with your nurse or surgeon.
3. Antacids: You will be taking famotidine tablets, 20 mg twice 
daily, for one month. This medicine reduces stomach acid 
production. Please crush.
4. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs). Examples include, but are not limited to Aleve, 
Arthrotec, aspirin, Bufferin, diclofenac, Ecotrin, etodolac, 
ibuprofen, Indocin, indomethacin, Feldene, ketorolac, 
meclofenamate, meloxicam, Midol, Motrin, nambumetone, Naprosyn, 
Naproxen, Nuprin, oxaprozin, Piroxicam, Relafen, Toradol and 
Voltaren. These agents may cause bleeding and ulcers in your 
digestive system. If you are unclear whether a medication is 
considered an NSAID, please ask call your nurse or ask your 
pharmacist.
5.  Vitamins/ minerals: You may resume a chewable multivitamin, 
however, please discuss when to resume additional vitamin and 
mineral supplements with your bariatric dietitian.

Activity:
You should continue walking frequently throughout the day right 
after surgery; you may climb stairs.  
You may resume moderate exercise at your discretion, but avoid 
performing abdominal exercises or lifting items greater than10 
to 15 pounds for six weeks.

Wound Care:
You may remove any remaining gauze from over your incisions.  
You will have thin paper strips (Steri-Strips) over your 
incision; please, remove any remaining Steri-Strip seven to 10 
days after surgery.   
You may shower 48 hours following your surgery; avoid scrubbing 
your incisions and gently pat them dry.  Avoid tub baths or 
swimming until cleared by your surgeon. 
If there is clear drainage from your incisions, cover with 
clean, dry gauze. 
Please call the doctor if you have increased pain, swelling, 
redness, cloudy, bloody or foul smelling drainage from the 
incision sites. 
Avoid direct sun exposure to the incision area for up to 24 
months.
Do not use any ointments on the incision unless you were told 
otherwise.

 
Followup Instructions:
___